Aberdeen Group’s Halozyme HALO Stock Holding History

Aberdeen Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-78,490	Closed	-$4.08M	–	964
2025 Q2	$4.08M	Sell	78,490 -28,247	-26%	-$1.61M	0.01%	726
2025 Q1	$6.81M	Sell	106,737 -21,933	-17%	-$1.27M	0.01%	644
2024 Q4	$6.15M	Buy	+128,670	New	+$6.6M	0.01%	610

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aberdeen Group's HALO Position: Q3 2025 in Review

Aberdeen Group sold out of Halozyme (HALO) in Q3 2025, closing a stake of 78,490 shares — an estimated $4.08M sold.

Aberdeen Group first reported a position in HALO in Q4 2024 and held it in 3 quarters. The position peaked at $6.81M in Q1 2025. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

Aberdeen Group reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
Aberdeen Group sold 78,490 Halozyme shares in Q3 2025, an estimated $4.08M.
Aberdeen Group first reported a position in Halozyme in Q4 2024 and held it in 3 quarters.
Aberdeen Group's Halozyme position peaked at $6.81M in Q1 2025.
602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Aberdeen Group's 13F filing for Q3 2025, filed 7 Nov 2025.